Understanding monocyte-driven neuroinflammation in Alzheimer’s disease using human cortical organoid microphysiological systems
Science Advances · 22.08.2025 · 11 (34)
DOI: 10.1126/sciadv.adu2708 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 22.08.2025. Verfasst von Chunhui Tian und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intelligent Systems Engineering, Indiana University Bloomington, IN 47405, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Monocytes, Organoids, Neuroinflammatory Diseases. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIA NIH HHS, NIDA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Increasing evidence strongly links neuroinflammation to Alzheimer’s disease (AD) pathogenesis. Peripheral monocytes are crucial components of the human immune system, but their contribution to AD pathogenesis is still largely understudied partially due to limited human models. Here, we introduce human cortical organoid microphysiological systems (hCO-MPSs) to study AD monocyte-mediated neuroinflammation. By culturing doughnut-shape organoids on 3D-printed devices within standard 96-well plates, we generate hCO-MPSs with reduced necrosis, minimized hypoxia, and improved viability. Using these models, we found that monocytes from AD patients exhibit increased infiltration ability, decreased amyloid-β clearance capacity, and stronger inflammatory response than monocytes from age-matched control donors. Moreover, we observed that AD monocytes induce pro-inflammatory effects such as elevated astrocyte activation and neuronal apoptosis. Furthermore, the marked increase in IL1B and CCL3 expression underscores their pivotal role in AD monocyte-mediated neuroinflammation. Our findings provide insight into understanding monocytes’ role in AD pathogenesis, and our lab-compatible MPS models may offer a promising way for studying various neuroinflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Intelligent Systems Engineering, Indiana University Bloomington, IN 47405, USA.
- Department of Neurodegenerative Diseases, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.
- Irell & Manella Graduate School of Biological Sciences, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.
- Department of Molecular and Cellular Biochemistry, Indiana University, Bloomington, IN 47405, USA.
- Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 6068507, Japan.
- Stark Neurosciences Research Institute, and Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
ORCID-Profile: Chunhui Tian, Jonas Cerneckis, Hongwei Cai, Hengyao Niu, Kazuo Takayama, Jungsu Kim, Mingxia Gu, Takahisa Kanekiyo, Feng Guo
Förderung
- NIAID NIH HHS
- NIA NIH HHS
- NIDA NIH HHS
Zitieren
APA
Tian, C., Ao, Z., Cerneckis, J., Cai, H., Chen, L., Niu, H., Takayama, K., Kim, J., Shi, Y., Gu, M., Kanekiyo, T., & Guo, F. (2025). Understanding monocyte-driven neuroinflammation in Alzheimer’s disease using human cortical organoid microphysiological systems. Science Advances, 11(34). https://doi.org/10.1126/sciadv.adu2708
Vancouver
Tian C, Ao Z, Cerneckis J, Cai H, Chen L, Niu H, et al. Understanding monocyte-driven neuroinflammation in Alzheimer’s disease using human cortical organoid microphysiological systems. Science Advances. 2025;11(34). doi:10.1126/sciadv.adu2708
BibTeX
@article{Tian2025,
author = {Tian, Chunhui and Ao, Zheng and Cerneckis, Jonas and Cai, Hongwei and Chen, Lei and Niu, Hengyao and Takayama, Kazuo and Kim, Jungsu and Shi, Yanhong and Gu, Mingxia and Kanekiyo, Takahisa and Guo, Feng},
title = {Understanding monocyte-driven neuroinflammation in Alzheimer’s disease using human cortical organoid microphysiological systems},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {34},
doi = {10.1126/sciadv.adu2708}
}
EUVIMED